Immunization with low doses of HIV-1 tat DNA delivered by novel cationic block copolymers induces CTL responses against Tat

By Caputo A.   Gavioli R.   Altavilla G.   Brocca-Cofano E.   Boarini C.   Betti M.   Castaldello A.   Lorenzini F.   Micheletti F.   Cafaro A.   Sparnacci K.   Laus M.   Tondelli L.   Ensoli B.  

Vaccine, Vol. 21, Iss. 11, 2003-03 ,pp. : 1103-1111

Elsevier

Access to resources Recommend Favorite

Adjuvant effect of multi-CpG motifs on an HIV-1 DNA vaccine

By Kojima Y.   Xin K.-Q.   Ooki T.   Hamajima K.   Oikawa T.   Shinoda K.   Ozaki T.   Hoshino Y.   Jounai N.   Nakazawa M.   Klinman D.   Okuda K.  

Vaccine, Vol. 20, Iss. 23, 2002-07 ,pp. : 2857-2865

Elsevier

Access to resources Recommend Favorite

Immunogenicity of an HIV-1 gag DNA vaccine carried by attenuated Shigella

By Xu F.   Hong M.   Ulmer J.B.  

Vaccine, Vol. 21, Iss. 7, 2003-01 ,pp. : 644-648

Elsevier

Access to resources Recommend Favorite

Characterization of HIV-1 Tat proteins mutated in the transactivation domain for prophylactic and therapeutic application

By Betti M.   Voltan R.   Marchisio M.   Mantovani I.   Boarini C.   Nappi F.   Ensoli B.   Caputo A.  

Vaccine, Vol. 19, Iss. 25, 2001-05 ,pp. : 3408-3419

Elsevier

Access to resources Recommend Favorite

Minimization of chronic plasma viremia in rhesus macaques immunized with synthetic HIV-1 Tat peptides and infected with a chimeric simian/human immunodeficiency virus (SHIV 33 )

By Goldstein G.   Manson K.   Tribbick G.   Smith R.  

Vaccine, Vol. 18, Iss. 25, 2000-06 ,pp. : 2789-2795

Elsevier

Access to resources Recommend Favorite